pyronaridine has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilera, RJ; Baca, ST; Contreras, L; DeJesus, RE; Gutierrez, DA; Larragoity, M; Martinez, A; Varela-Ramirez, A; Villanueva, PJ | 1 |
| Qi, J; Wang, CY; Wang, JH; Wang, SB; Yang, CZ; Yang, M | 1 |
2 other study(ies) available for pyronaridine and Breast Cancer
| Article | Year |
|---|---|
Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Biological Transport; Breast Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; DNA Fragmentation; Enzyme Activation; Humans; Leukemia; Lymphoma; Membrane Potential, Mitochondrial; Naphthyridines; Phosphatidylserines | 2018 |
Function and mechanism of pyronaridine: a new inhibitor of P-glycoprotein-mediated multidrug resistance.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Female; Genes, MDR; Humans; K562 Cells; Naphthyridines; Tumor Cells, Cultured | 2002 |